Evidence map›Paper›PMID 25604352›Full record

ArticleBMC medicine2014

Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications.

Ana Marušić, Darko Hren, Bernadette Mansi, Neil Lineberry, Ananya Bhattacharya, Maureen Garrity, Juli Clark, Thomas Gesell, Susan Glasser, John Gonzalez and 4 more

Abstract readLetter
In one paragraph

Article in BMC medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Authorship transparency and equity in otolaryngology and maxillofacial surgery: current practices and the potential impact of large language models.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Transparency in authors' contributions and responsibilities to promote integrity in scientific publication.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  13. The Malversations of Authorship - Current Status in Academic Community and How to Prevent It.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2018
    Article
  14. Article
  15. Authors and Contributors in Scientific and Medical Publications.Indian journal of clinical biochemistry : IJCB · 2016
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ana MarušićDepartment of Research in Biomedicine and Health, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia. ana.marusic@mefst.hr.
Darko HrenUniversity of Split School of Humanities and Social Sciences, Split, Croatia. dhren@ffst.hr.
Bernadette MansiGlaxoSmithKline, King of Prussia, PA, USA. Bernadette.A.Mansi@gsk.com.
Neil LineberryMember of MPIP Initiative Steering Committee, Boston, MA, USA. neil.lineberry@navigant.com.
Ananya BhattacharyaMember of MPIP Initiative Steering Committee, Boston, MA, USA. ananya.bhattacharya@bms.com.
Maureen GarrityMember of MPIP Initiative Steering Committee, Boston, MA, USA. maureen.garrity@astellas.com.
Juli ClarkMember of MPIP Initiative Steering Committee, Boston, MA, USA. clarkjk@amgen.com.
Thomas GesellMember of MPIP Initiative Steering Committee, Boston, MA, USA. Thomas.Gesell@envisionpharmagroup.com.
Susan GlasserMember of MPIP Initiative Steering Committee, Boston, MA, USA. SGlasser@its.jnj.com.
John GonzalezMember of MPIP Initiative Steering Committee, Boston, MA, USA. John.Gonzalez@astrazeneca.com.
Carolyn HustadMember of MPIP Initiative Steering Committee, Boston, MA, USA. carolyn_hustad@merck.com.
Mary-Margaret LannonMember of MPIP Initiative Steering Committee, Boston, MA, USA. mary.lannon@takeda.com.
LaVerne A MooneyMember of MPIP Initiative Steering Committee, Boston, MA, USA. Laverne.Mooney@pfizer.com.
Teresa PeñaMember of MPIP Initiative Steering Committee, Boston, MA, USA. Teresa.Pena@astrazeneca.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Authorship guidelines have established criteria to guide author selection based on significance of contribution and helped to define associated responsibilities and accountabilities for the published findings. However, low awareness, variable interpretation, and inconsistent application of these guidelines can lead to confusion and a lack of transparency when recognizing those who merit authorship. This article describes a research project led by the Medical Publishing Insights and Practices (MPIP) Initiative to identify current challenges when determining authorship for industry-sponsored clinical trials and develop an improved approach to facilitate decision-making when recognizing authors from related publications. A total of 498 clinical investigators, journal editors, publication professionals and medical writers were surveyed to understand better how they would adjudicate challenging, real-world authorship case scenarios, determine the perceived frequency of each scenario and rate their confidence in the responses provided. Multiple rounds of discussions about these results with journal editors, clinical investigators and industry representatives led to the development of key recommendations intended to enhance transparency when determining authorship. These included forming a representative group to establish authorship criteria early in a trial, having all trial contributors agree to these criteria and documenting trial contributions to objectively determine who warrants an invitation to participate in the manuscript development process. The resulting Five-step Authorship Framework is designed to create a more standardized approach when determining authorship for clinical trial publications. Overall, these recommendations aim to facilitate more transparent authorship decisions and help readers better assess the credibility of results and perspectives of the authors for medical research more broadly. Please see related article: http://www.biomedcentral.com/1741-7015/12/214.

Indexed as

Clinical Trials as TopicFinancial SupportPractice Guidelines as TopicAuthorshipBiomedical ResearchConflict of InterestDecision MakingDisclosureDrug IndustryEthics, ProfessionalHumansPublications

Identifiers

PMID25604352
PMCPMC4209055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.